Coastline Trust Co Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Coastline Trust Co reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 11,731 shares of the healthcare conglomerate’s stock after selling 2,796 shares during the period. UnitedHealth Group comprises about 0.8% of Coastline Trust Co’s holdings, making the stock its 29th largest position. Coastline Trust Co’s holdings in UnitedHealth Group were worth $6,859,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Tealwood Asset Management Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $2,905,000. Asset Planning Services Inc. LA ADV raised its holdings in UnitedHealth Group by 1.2% during the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after purchasing an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC boosted its holdings in shares of UnitedHealth Group by 13.7% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after buying an additional 3,006 shares in the last quarter. Americana Partners LLC raised its stake in UnitedHealth Group by 10.8% during the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after acquiring an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. boosted its stake in UnitedHealth Group by 14.8% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after acquiring an additional 1,283 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on UNH. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Barclays reduced their target price on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Finally, Truist Financial restated a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $592.18 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market cap of $544.97 billion, a PE ratio of 38.58, a P/E/G ratio of 1.78 and a beta of 0.58. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a fifty day moving average price of $582.84 and a 200 day moving average price of $549.06.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the company earned $6.56 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.